ciprofibrate has been researched along with Body Weight in 15 studies
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mixed hyperlipidemia is a common risk factor for cardiovascular disease." | 6.70 | Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. ( Aguilar-Salinas, CA; Fanghänel-Salmón, G; Gómez Pérez, FJ; González-Valdez, H; Gulías-Herrero, A; Meza, E; Monterrubio-Flores, EA; Montes, J; Sánchez, L, 2001) |
| " In the present study the influence of a four-week daily oral administration of 2 mg/kg body weight ciprofibrate (CAS 52214-84-3) or of 100 mg/kg body weight clofibric acid (CAS 882-09-7) was compared to that of the respective doses of their newly synthesized glycine conjugates in adult male lean and obese Zucker rats." | 3.74 | Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats. ( Deufel, T; Fleck, C; Karge, E; Lupp, A; Oelschlägers, H, 2008) |
| "Rainbow trout (Salmo gairdneri), average body weight of 450 g, were treated with 15, 25, or 35 mg/kg of ciprofibrate via intraperitoneal injection every other day for 2 to 3 weeks." | 3.68 | Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate. ( Baldwin, LA; Calabrese, EJ; Kostecki, PT; Yang, JH, 1990) |
| "Mixed hyperlipidemia is a common risk factor for cardiovascular disease." | 2.70 | Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. ( Aguilar-Salinas, CA; Fanghänel-Salmón, G; Gómez Pérez, FJ; González-Valdez, H; Gulías-Herrero, A; Meza, E; Monterrubio-Flores, EA; Montes, J; Sánchez, L, 2001) |
| "Ciprofibrate treatment also reduced 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity to a lesser extent but had no effect on 17-hydroxylase (17-OHase) activity." | 1.33 | Effects of ciprofibrate on testicular and adrenal steroidogenic enzymes in the rat. ( Cooke, GM; Curran, IH; Hierlihy, AM; Karamanos, L; Mehta, R; Price, CA, 2006) |
| "Ciprofibrate was fed to female Sprague-Dawley rats at concentrations of 0, 0." | 1.28 | Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats. ( Chow, CK; Glauert, HP; Srinivasan, SR, 1990) |
| "Nafenopin was also added to either a high carbohydrate (70% of kilocalories from glucose) or high fat (70% of kilocalories from lard) diet and fed to rats for either 1 or 3 weeks." | 1.27 | The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle. ( MacDonald, RS; Swan, PB, 1986) |
| "Ciprofibrate was convenient to take and was without subjective side effects." | 1.26 | Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. ( Olsson, AG; Orö, L, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lupp, A | 1 |
| Karge, E | 1 |
| Deufel, T | 1 |
| Oelschlägers, H | 1 |
| Fleck, C | 1 |
| Hierlihy, AM | 1 |
| Cooke, GM | 1 |
| Curran, IH | 1 |
| Mehta, R | 1 |
| Karamanos, L | 1 |
| Price, CA | 1 |
| Calfee-Mason, KG | 1 |
| Lee, EY | 1 |
| Spear, BT | 1 |
| Glauert, HP | 3 |
| Rao, MS | 2 |
| Lalwani, ND | 1 |
| Watanabe, TK | 1 |
| Reddy, JK | 1 |
| Olsson, AG | 1 |
| Orö, L | 1 |
| Espandiari, P | 1 |
| Thomas, VA | 1 |
| O'Brien, M | 1 |
| Noonan, D | 1 |
| Robertson, LW | 1 |
| Pacot, C | 1 |
| Charmoillaux, M | 1 |
| Goudonnet, H | 1 |
| Truchot, RC | 1 |
| Latruffe, N | 1 |
| Mikhailidis, DP | 1 |
| Ganotakis, ES | 1 |
| Spyropoulos, KA | 1 |
| Jagroop, IA | 1 |
| Byrne, DJ | 1 |
| Winder, AF | 1 |
| Aguilar-Salinas, CA | 1 |
| Fanghänel-Salmón, G | 1 |
| Meza, E | 1 |
| Montes, J | 1 |
| Gulías-Herrero, A | 1 |
| Sánchez, L | 1 |
| Monterrubio-Flores, EA | 1 |
| González-Valdez, H | 1 |
| Gómez Pérez, FJ | 1 |
| Makowska, JM | 2 |
| Gibson, GG | 2 |
| Bonner, FW | 1 |
| Yeldandi, AV | 1 |
| Subbarao, V | 1 |
| Yang, JH | 1 |
| Kostecki, PT | 1 |
| Calabrese, EJ | 1 |
| Baldwin, LA | 1 |
| Srinivasan, SR | 1 |
| Chow, CK | 1 |
| Anders, C | 1 |
| Goldfarb, PS | 1 |
| Bonner, F | 1 |
| MacDonald, RS | 1 |
| Swan, PB | 1 |
1 trial available for ciprofibrate and Body Weight
| Article | Year |
|---|---|
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Topics: Adolescent; Adult; Aged; Apolipoproteins B; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, | 2001 |
14 other studies available for ciprofibrate and Body Weight
| Article | Year |
|---|---|
Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Clofibric Acid; Cytochrome P-450 Enzym | 2008 |
Effects of ciprofibrate on testicular and adrenal steroidogenic enzymes in the rat.
Topics: 17-Hydroxysteroid Dehydrogenases; Administration, Oral; Adrenal Glands; Animals; Body Weight; Choles | 2006 |
Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Topics: Acyl-CoA Oxidase; Animals; Apoptosis; Blotting, Western; Body Weight; Cell Nucleus; Clofibric Acid; | 2008 |
Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Topics: Animals; Anisoles; Antioxidants; Body Weight; Butylated Hydroxyanisole; Carcinogens; Clofibrate; Clo | 1984 |
Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Sedimentation; Body Weight; Cholesterol; Ch | 1982 |
The herbicide dicamba (2-methoxy-3,6-dichlorobenzoic acid) is a peroxisome proliferator in rats.
Topics: Acyl-CoA Oxidase; Animals; Base Sequence; Body Weight; Clofibric Acid; Cytochrome P-450 CYP4A; Cytoc | 1995 |
Role of thyroid state on induction by ciprofibrate of laurate hydroxylase and peroxisomal enzymes in rat liver microsomes.
Topics: Animals; Body Weight; Clofibric Acid; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Enzyme | 1993 |
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
Topics: Body Weight; Cardiovascular Diseases; Clofibric Acid; Female; Fibric Acids; Fibrinogen; Humans; Hype | 1998 |
Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation.
Topics: Animals; Body Weight; Callithrix; Clofibric Acid; Cricetinae; Cytochrome P-450 Enzyme System; Enzyme | 1992 |
Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats.
Topics: Animals; Body Weight; Clofibric Acid; Diet; Diethylhexyl Phthalate; Fibric Acids; Liver Neoplasms, E | 1990 |
Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate.
Topics: Acyl-CoA Oxidase; Analysis of Variance; Animals; Blotting, Western; Body Weight; Catalase; Clofibrat | 1990 |
Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Topics: Administration, Oral; Animals; Body Weight; Clofibrate; Clofibric Acid; DNA; Female; Fibric Acids; H | 1990 |
Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Topics: Administration, Oral; Animals; Body Weight; Cell Division; Clofibrate; Clofibric Acid; Cytochrome P- | 1990 |
The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
Topics: Animals; Body Weight; Catalase; Clofibrate; Clofibric Acid; Fibric Acids; Hypolipidemic Agents; Male | 1986 |